Foster & Motley’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.3M Sell
46,297
-965
-2% -$225K 0.58% 36
2025
Q4
$9.78M Sell
47,262
-952
-2% -$188K 0.52% 42
2025
Q3
$8.94M Sell
48,214
-1,171
-2% -$201K 0.48% 51
2025
Q2
$7.54M Buy
49,385
+998
+2% +$153K 0.44% 57
2025
Q1
$8.02M Buy
48,387
+1,598
+3% +$250K 0.51% 45
2024
Q4
$6.77M Buy
46,789
+145
+0.3% +$22.5K 0.44% 59
2024
Q3
$7.56M Sell
46,644
-1,087
-2% -$173K 0.48% 50
2024
Q2
$6.98M Buy
47,731
+1,298
+3% +$193K 0.48% 49
2024
Q1
$7.34M Buy
46,433
+576
+1% +$91.7K 0.51% 46
2023
Q4
$7.19M Buy
45,857
+2,584
+6% +$396K 0.53% 42
2023
Q3
$6.74M Sell
43,273
-1,072
-2% -$177K 0.55% 41
2023
Q2
$7.34M Sell
44,345
-134
-0.3% -$21.6K 0.57% 37
2023
Q1
$6.89M Sell
44,479
-910
-2% -$147K 0.56% 34
2022
Q4
$8.02M Buy
45,389
+271
+0.6% +$46.8K 0.68% 30
2022
Q3
$7.37M Sell
45,118
-685
-1% -$116K 0.7% 32
2022
Q2
$8.13M Sell
45,803
-1,289
-3% -$230K 0.71% 32
2022
Q1
$8.35M Sell
47,092
-1,364
-3% -$232K 0.65% 37
2021
Q4
$8.29M Sell
48,456
-76
-0.2% -$12.4K 0.65% 39
2021
Q3
$7.84M Sell
48,532
-994
-2% -$170K 0.65% 39
2021
Q2
$8.16M Buy
49,526
+745
+2% +$123K 0.68% 37
2021
Q1
$8.02M Buy
48,781
+695
+1% +$112K 0.67% 36
2020
Q4
$7.57M Buy
48,086
+4,104
+9% +$606K 0.73% 35
2020
Q3
$6.55M Sell
43,982
-1,118
-2% -$165K 0.77% 32
2020
Q2
$6.34M Sell
45,100
-1,037
-2% -$151K 0.79% 32
2020
Q1
$6.05M Sell
46,137
-959
-2% -$136K 0.9% 26
2019
Q4
$6.87M Sell
47,096
-1,940
-4% -$263K 0.86% 30
2019
Q3
$6.34M Sell
49,036
-725
-1% -$95.5K 0.86% 29
2019
Q2
$6.93M Sell
49,761
-1,070
-2% -$148K 0.97% 24
2019
Q1
$7.11M Sell
50,831
-1,533
-3% -$205K 1.02% 24
2018
Q4
$6.76M Sell
52,364
-1,101
-2% -$154K 1.08% 23
2018
Q3
$7.39M Sell
53,465
-3,585
-6% -$476K 1.11% 24
2018
Q2
$6.92M Sell
57,050
-1,080
-2% -$135K 1.1% 24
2018
Q1
$7.45M Sell
58,130
-2,512
-4% -$340K 1.21% 22
2017
Q4
$8.47M Buy
60,642
+1,076
+2% +$150K 1.35% 21
2017
Q3
$7.74M Buy
59,566
+996
+2% +$132K 1.33% 22
2017
Q2
$7.75M Buy
58,570
+702
+1% +$89.6K 1.37% 23
2017
Q1
$7.21M Buy
57,868
+292
+0.5% +$34.9K 1.31% 26
2016
Q4
$6.63M Buy
57,576
+4,182
+8% +$483K 1.27% 28
2016
Q3
$6.31M Buy
53,394
+15,200
+40% +$1.84M 1.22% 28
2016
Q2
$4.63M Buy
38,194
+3,286
+9% +$373K 0.91% 39
2016
Q1
$3.78M Buy
34,908
+463
+1% +$47.9K 0.76% 47
2015
Q4
$3.54M Sell
34,445
-2,579
-7% -$259K 0.75% 49
2015
Q3
$3.46M Sell
37,024
-98
-0.3% -$9.48K 0.79% 50
2015
Q2
$3.62M Sell
37,122
-3,566
-9% -$357K 0.79% 48
2015
Q1
$4.09M Sell
40,688
-767
-2% -$78K 0.9% 42
2014
Q4
$4.33M Sell
41,455
-14,213
-26% -$1.5M 0.98% 36
2014
Q3
$5.93M Sell
55,668
-2,037
-4% -$211K 1.38% 28
2014
Q2
$6.04M Sell
57,705
-2,734
-5% -$276K 1.39% 25
2014
Q1
$5.94M Buy
60,439
+3,456
+6% +$320K 1.46% 21
2013
Q4
$5.22M Buy
56,983
+8,041
+16% +$741K 1.32% 28
2013
Q3
$4.24M Buy
48,942
+7,253
+17% +$651K 1.13% 35
2013
Q2
$3.58M Buy
+41,689
New +$3.54M 0.99% 41

Other funds holding JNJ

Foster & Motley's JNJ Position: Q1 2026 in Review

Foster & Motley reduced its Johnson & Johnson (JNJ) stake by 2% in Q1 2026, selling an estimated $225K and leaving 46,297 shares worth $11.3M. The position accounts for 0.58% of the portfolio, ranked #36.

Foster & Motley first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Foster & Motley held 46,297 shares of Johnson & Johnson worth $11.3M as of Q1 2026.
  • Foster & Motley sold 965 Johnson & Johnson shares in Q1 2026, an estimated $225K.
  • Johnson & Johnson made up 0.58% of Foster & Motley's portfolio in Q1 2026, its #36 holding.
  • Foster & Motley first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Foster & Motley's 13F filing for Q1 2026, filed 21 Apr 2026.